Cardiac Arrest, Cardiogenic Shock, Therapeutic Hypothermia Timothy - - PowerPoint PPT Presentation

cardiac arrest cardiogenic shock
SMART_READER_LITE
LIVE PREVIEW

Cardiac Arrest, Cardiogenic Shock, Therapeutic Hypothermia Timothy - - PowerPoint PPT Presentation

Cardiac Arrest, Cardiogenic Shock, Therapeutic Hypothermia Timothy D. Henry, MD Director of Cardiology Cedars-Sinai Heart Institute Disclosures: Nothing to disclose 3 Out-of-Hospital Cardiac Arrest 48 year old male presents to ER as


slide-1
SLIDE 1

Cardiac Arrest, Cardiogenic Shock, Therapeutic Hypothermia

Timothy D. Henry, MD Director of Cardiology Cedars-Sinai Heart Institute

slide-2
SLIDE 2

Disclosures:

▪ Nothing to disclose

slide-3
SLIDE 3

3

  • 48 year old male presents to ER as an out of hospital

cardiac arrest: witness report seizure like activity, then slumped in his chair.

  • EMS arrival: Somnolent, then arrested, Initial rhythm

VF, multiple shocks, 4 epi and amio 300 in field.

  • Arrival to ER with ongoing CPR in PEA.
  • Risk factors, Previous History and Medications:

 None known

Out-of-Hospital Cardiac Arrest

slide-4
SLIDE 4

4

  • Given age and initial rhythm, CT surgery called for VA-

ECMO . Upon initiating ECMO , he was noted to have spontaneous respirations and blood pressure 140/90.

  • First EKG:

Out-of-Hospital Cardiac Arrest

slide-5
SLIDE 5

5

EKG#1 @ 12:20

slide-6
SLIDE 6

6

  • Troponin #1 11:45 0.18

 No ABG or lactate on arrival

  • Taken Emergently to Cath Lab
  • Timeline

 Arrival to ER: 11:39 AM  EKG: 12:20  Door to ECMO Initiation: 30 minutes

48 year old with OHCA

slide-7
SLIDE 7

7

Baseline Angiogram

slide-8
SLIDE 8
  • Aspiration: yes or no?
  • Multivessel PCI (D Cx) yes or no?
  • ECMO: yes or no Impella?
  • Therapeutic Hypothermia: yes or no,

what target, how long?

LAD culprit PCI but what else?

slide-9
SLIDE 9

9

  • Intervention

 Aspiration thrombectomy of the LAD.  PCI to the proximal to mid LAD using a 3.5 x 38

Xience Alpine DES.

 PCI of the distal left circumflex using a 3.0 x 15

Xience Alpine DES.

Placement of an Impella CP 4.0

  • Peak Troponin: 46

Cath Lab

slide-10
SLIDE 10

10

Post PCI

slide-11
SLIDE 11

11

EKG Post PCI

slide-12
SLIDE 12

12

Low normal LVEF 50 % with hypokinesis of the mid to apical septal wall otherwise normal

TTE: Hospital Day #1

slide-13
SLIDE 13

13

  • Therapeutic Hypothermia.

 Initiated one hour after presentation via ECMO

circuit, cooled to 33 degrees

 Rewarmed after 24 hours  No focal neurologic deficits

  • MCS

 Impella removed Hospital Day #2  Decannulated Hospital Day #4

  • Discharged Hospital Day #14
  • 3 month follow up: Doing well, returned to work, playing

soccer, on DAPT, no anginal complaints

Hospital Course

slide-14
SLIDE 14

Simple case?

slide-15
SLIDE 15
slide-16
SLIDE 16
slide-17
SLIDE 17

Cardiac Arrest

  • Out-of-hospital cardiac arrest (OOHCA)
  • 295,000 people annually in the US
  • 7.9% median survival rate
  • Anoxic encephalopathy and neurologic deficits
  • Therapeutic hypothermia (TH) clinical trials
  • ILCOR recommendation for TH after resuscitation

Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics-2009 update. Circulation 2009;119:e21-e181.

slide-18
SLIDE 18

18

OHCA survival to hospital discharge by 5-year time periods

Comilla Sasson et al. Circ Cardiovasc Qual Outcomes. 2010;3:63- 81

slide-19
SLIDE 19

Survival improves to 50- 60% with Favorable neurological outcomes in 86% of survivors

With hypothermia and PCI!

Rab et al. JACC 2015;66:62-73

slide-20
SLIDE 20
slide-21
SLIDE 21
slide-22
SLIDE 22

Early Transport to Cath Lab for ECMO and Revasc in Refractory VF (?OHCA)

slide-23
SLIDE 23

Interaction of Cardiac Arrest and Cardiogenic Shock

Cardiogenic Shock (+) Cardiogenic Shock (–) Cardiac Arrest (+) 184 Patients In-hospital Mortality: 47.3% 1 – Year Mortality: 51.6% 317 Patients In-hospital Mortality: 20.2% 1 – Year Mortality: 22.7% Cardiac Arrest (–) 259 Patients In-hospital Mortality: 25.1% 1 – Year Mortality: 33.6% 4157 Patients In-hospital Mortality: 1.7% 1 – Year Mortality: 5.5%

slide-24
SLIDE 24
slide-25
SLIDE 25
slide-26
SLIDE 26

26

Survival related to outcome of PCI

Florence Dumas et al. Circ Cardiovasc Interv. 2010;3:200-207

slide-27
SLIDE 27

Early predictors of survival in OHCA

Florence Dumas et al. Circ Cardiovasc Interv. 2010;3:200- 207

slide-28
SLIDE 28

28

Early Transport to Cath Lab for ECMO and Revascularization in Refractory Ventricular Fibrillation

Out of Hospital

  • VF/VT Initial rhythm
  • DCCV x3 and 300mg Amiodarone without ROSC
  • Time to CCL <30 min

Initial CCL

  • ABG and lactate
  • Stop if: ETCO2<10mmHg, PaO2<50mmHg or Lactate >18

mmol/L

  • If ROSC, immediate Cor Angio +/- IABP.
  • If no ROSC, ECLS , then Cor Angio +/- IABP.
  • Continue ACLS/ECLS for 90 minutes/PCI; if no ROSC by 90

minutes, declared dead

slide-29
SLIDE 29

29

slide-30
SLIDE 30

Characteristics of Survivors

30

slide-31
SLIDE 31

Complication Rate

31

  • 13% on ECMO had Vascular Complications
  • 4 with significant retroperitoneal bleeding requiring transfusion
  • 3 developed an ischemic leg after thrombosis of the distal perfusion cath
slide-32
SLIDE 32

32

Comparison Between the Refractory VF/VT Protocol and the Historical Comparison Group

slide-33
SLIDE 33
slide-34
SLIDE 34

Cooling Outcomes

Alive at hospital discharge with favourable neurological recovery

Abbott Northwestern Hospital 53/96 55.2%

  • Survival by diagnosis

– STEMI: 33/50 66.0% – Other: 20/46 43.5%

  • Survival by initial rhythm

– VF/VT: 47/75 62.6% – PEA/Asystole: 5/19 26.3%

slide-35
SLIDE 35

Transfer Outcomes Transfer = Blue line, ANW = Red line

0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 Fraction surviving 1 10

7 5 4 3 2

100

60 40 20

1000

500 300

Days Arrest to Death or Last Know n Alive